MCID: ACT078
MIFTS: 45

Acute Porphyria malady

Categories: Genetic diseases, Metabolic diseases, Rare diseases, Blood diseases, Liver diseases

Aliases & Classifications for Acute Porphyria

About this section

Aliases & Descriptions for Acute Porphyria:

Name: Acute Porphyria 11 13
Porphyrias, Hepatic 37 66
 
Acute Intermittent Porphyria 66
Hepatic Porphyria 11

Classifications:



External Ids:

Disease Ontology11 DOID:3133
SNOMED-CT60 55056006
MeSH37 D017094

Summaries for Acute Porphyria

About this section
Disease Ontology:11 A porphyria that has symptom abdominal pain, has symptom neuropathy, has symptom autonomic instability and has symptom psychosis.

MalaCards based summary: Acute Porphyria, also known as porphyrias, hepatic, is related to porphyria cutanea tarda and coproporphyria, and has symptoms including abdominal pain, neuropathy and autonomic instability. An important gene associated with Acute Porphyria is HMBS (Hydroxymethylbilane Synthase), and among its related pathways are Glycine, serine and threonine metabolism and Porphyrin and chlorophyll metabolism. The drugs chlorpromazine and chlorpromazine hydrochloride have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and bone, and related mouse phenotypes are homeostasis/metabolism and mortality/aging.

Related Diseases for Acute Porphyria

About this section

Diseases in the Porphyria family:

acute porphyria Congenital Porphyria
Urod-Related Porphyrias

Diseases related to Acute Porphyria via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 39)
idRelated DiseaseScoreTop Affiliating Genes
1porphyria cutanea tarda27.7ALAD, CPOX, HFE, HMBS, PPOX, UROD
2coproporphyria25.8ALAD, ALAS1, ALAS2, CPOX, FECH, HMBS
3porphyria, acute hepatic11.6
4porphyria11.2
5porphyria, acute intermittent11.0
6chester porphyria10.6
7protoporphyria, erythropoietic, autosomal recessive10.0
8neuropathy9.9
9posterior foramen magnum meningioma9.9FECH, HFE
10y chromosome infertility9.8ALAS2, FECH
11hepatitis9.8
12slate pneumoconiosis9.7HFE, UROD
13myocardial infarction9.6
14acute myocardial infarction9.6
15atherosclerosis9.6
16brucellosis9.6
17cerebral atherosclerosis9.6
18polyneuropathy9.6
19pericarditis9.6
20constipation9.6
21cerebritis9.6
22hyperthyroidism9.6
23myocarditis9.6
24meningitis9.6
25chiari malformation9.6
26binswanger's disease9.6
27pyridoxine deficiency9.6
28encephalopathy9.6
29metal metabolism disorder9.5ALAS1, ALAS2, FECH
30atransferrinemia9.1ALAS2, HFE
31nasu-hakola disease9.0ALAS2, HFE, UROD
32intestinal tuberculosis9.0ALAS2, FECH, UROD, UROS
33aarskog-scott syndrome8.9ALAD, ALAS2, FECH, UROS
34migraine, with or without aura 138.6ALAD, CPOX, FECH, HMBS, UROD, UROS
35inflammatory bowel disease 28, early onset, autosomal recessive8.0ALAD, ALAS1, CPOX, FECH, HMBS, PPOX
36palmoplantar keratoderma, nagashima type7.9ALAD, ALAS2, CPOX, FECH, HMBS, PPOX
37porphyria variegata7.7ALAD, CPOX, FECH, HFE, HMBS, PPOX
38rift valley fever6.6ALAD, ALAS1, ALAS2, CPOX, FECH, HFE
39scalp dermatosis6.3ALAD, ALAS1, ALAS2, CPOX, FECH, HFE

Graphical network of the top 20 diseases related to Acute Porphyria:



Diseases related to acute porphyria

Symptoms for Acute Porphyria

About this section

Symptoms:

 11
  • abdominal pain
  • neuropathy
  • autonomic instability
  • psychosis

UMLS symptoms related to Acute Porphyria:


hepatomegaly, abdominal pain, constipation, diarrhea, dysuria, nausea, seizures, vomiting, cushingoid facies, weakness

Drugs & Therapeutics for Acute Porphyria

About this section

Drugs for Acute Porphyria (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 7)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DeferasiroxPhase 3, Phase 287201530-41-85493381
Synonyms:
Deferasiroxum
Deferasiroxum [inn-latin]
 
Exjade
ICL 670
ICL 670a
deferasirox
2
ColestipolPhase 2, Phase 3526658-42-4, 50925-79-662816
Synonyms:
Colestipolum
 
Colestipolum [INN-Latin]
Copolymer of bis(2-aminoethyl)amine and 2-(chloromethyl)oxirane
Epichlorohydrin-tetraethylenepentamine polymer
3
IronPhase 3, Phase 210807439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
4alpha-MSHPhase 3, Phase 214
5cysteineNutraceuticalPhase 3166
6
HydroxychloroquinePhase 2141118-42-33652
Synonyms:
(+-)-Hydroxychloroquine
(┬▒)-hydroxychloroquine
118-42-3
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
747-36-4 (sulfate (1:1) salt)
AC1L1GEW
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
EINECS 204-249-8
Gen-Hydroxychloroquine 200mg Tablets
HCQ
HMS502P04
Hidroxicloroquina
 
Hidroxicloroquina [INN-Spanish]
Hydroxychlorochin
Hydroxychloroguine
Hydroxychloroquine (INN)
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquine [INN:BAN]
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
ST072188
Spectrum2_001238
Spectrum5_001697
UNII-4QWG6N8QKH
WIN 1258
hydroxychloroquine
7
Aminolevulinic acid150106-60-5137
Synonyms:
106-60-5
35BEC718-C970-426A-9859-BF58284C60B4
5-ALA
5-Amino-4-oxo-Pentanoate
5-Amino-4-oxo-Pentanoic acid
5-Amino-4-oxopentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Amino-Levulinate
5-Amino-Levulinic acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Aminolevulinic acid
5-amino-levulinate
5451-09-2
AC-054
AC1L18K9
AKOS003587520
ALA
ALA-PDT
Aladerm
Amino-levulinic acid
Aminolevulinate
Aminolevulinic
Aminolevulinic acid
BIDD:GT0260
BSPBio_003407
C00430
CCRIS 8958
CHEBI:17549
CHEMBL601
CID137
CPD000857229
 
D07567
DALA
DB00855
DivK1c_006954
EINECS 203-414-1
I14-10101
KBio1_001898
KBio2_002062
KBio2_004630
KBio2_007198
KBio3_002627
KBioGR_001176
KBioSS_002062
Kerastick
LMFA01100055
LS-101793
Levulinic acid, 5-amino- (8CI)
MLS001333097
MLS001333098
MolPort-001-788-423
NCGC00178086-01
Pentanoic acid, 5-amino-4-oxo- (9CI)
SAM002589919
SMR000857229
SPBio_001843
ST50819610
SpecPlus_000858
Spectrum2_001662
Spectrum3_001654
Spectrum4_000618
Spectrum5_001505
Spectrum_001582
UNII-88755TAZ87
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
delta-aminolevulinic acid

Interventional clinical trials:

(show all 33)
idNameStatusNCT IDPhase
1Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea TardaCompletedNCT00599326Phase 3
2Sorbent Therapy of the Cutaneous PorphyriasCompletedNCT01422915Phase 2, Phase 3
3Phase III Study of L-Cysteine in Patients With Erythropoietic ProtoporphyriaCompletedNCT00004940Phase 3
4Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)CompletedNCT00979745Phase 3
5Phase III Confirmatory Study in Erythropoietic ProtoporphyriaActive, not recruitingNCT01605136Phase 3
6Porphozym in the Treatment of Acute Attacks in AIPCompletedNCT00418795Phase 2
7Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)CompletedNCT01097044Phase 2
8Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute PorphyriaCompletedNCT00004789Phase 1, Phase 2
9Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute PorphyriasCompletedNCT00004396Phase 2
10Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea TardaRecruitingNCT01573754Phase 2
11Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea TardaRecruitingNCT01284946Phase 2
12Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of PorphyriaRecruitingNCT02922413Phase 2
13Controlled Trial of Panhematin in Treatment of Acute Attacks of PorphyriaRecruitingNCT02180412Phase 2
14Heme Arginate in Cardiac Surgery PatientsNot yet recruitingNCT02142699Phase 2
15Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent PorphyriaCompletedNCT02082860Phase 1
16Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of PorphyriaCompletedNCT00004398Phase 1
17Hemin in Healthy SubjectsCompletedNCT00882804Phase 1
18Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of PorphyriaCompletedNCT00004397Phase 1
19A Phase 1 Study of ALN-AS1 in Patients With Acute Intermittent Porphyria (AIP)RecruitingNCT02452372Phase 1
20Risk Factors of Porphyria Cutanea Tarda (PCT)CompletedNCT00213772
21Study of the Pathogenesis of Porphyria Cutanea TardaCompletedNCT00005103
22Observational Study of Acute Intermittent Porphyria PatientsCompletedNCT02076763
23Study of Cysteine Hydrochloride for Erythropoietic ProtoporphyriaCompletedNCT00004831
24Study of Nutritional Factors in PorphyriaCompletedNCT00004788
25Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic AttacksCompletedNCT00004330
26Longitudinal Study of the PorphyriasRecruitingNCT01561157
27Clinical Diagnosis of Acute PorphyriaRecruitingNCT01568554
28Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))RecruitingNCT01880983
29Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial ImpactRecruitingNCT01688895
30Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic ProtoporphyriaRecruitingNCT00206869
31EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)Active, not recruitingNCT02240784
32Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)Not yet recruitingNCT01617642
33Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaWithdrawnNCT01550705

Search NIH Clinical Center for Acute Porphyria

Inferred drug relations via UMLS66/NDF-RT44:


Cochrane evidence based reviews: porphyrias, hepatic

Genetic Tests for Acute Porphyria

About this section

Anatomical Context for Acute Porphyria

About this section

MalaCards organs/tissues related to Acute Porphyria:

34
Liver, Testes, Bone, Bone marrow, Pineal, Globus pallidus, Brain

Animal Models for Acute Porphyria or affiliated genes

About this section

MGI Mouse Phenotypes related to Acute Porphyria:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053766.8ALAS2, FECH, HFE, HMBS, PC, PPOX
2MP:00107686.1ALAS1, ALAS2, FECH, HFE, HMBS, PC

Publications for Acute Porphyria

About this section

Articles related to Acute Porphyria:

(show top 50)    (show all 263)
idTitleAuthorsYear
1
Successful administration of sugammadex in a patient with acute porphyria: A case report. (24992602)
2014
2
How porphyrinogenic drugs modeling acute porphyria impair the hormonal status that regulates glucose metabolism. Their relevance in the onset of this disease. (21889565)
2011
3
Thomas Wakley, King George III and acute porphyria. (19966121)
2009
4
Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias. (17578481)
2007
5
Treatment of acute porphyrias. The importance of follow-up of patients and carriers]. (12809070)
2003
6
A study of 24-hour ambulatory blood pressure monitoring in cases of intermittent acute porphyria with hypertension: special reference to safety and efficacy of angiotensin-converting enzyme inhibitor (enalapril) therapy. (12674196)
2002
7
Treatment of acute porphyria. (11480131)
2001
8
Acute porphyria following commencement of indinavir. (10203389)
1999
9
Primary liver cancer in two sisters in Holland with intermittent acute porphyria. (9254746)
1997
10
Drug treatment in acute porphyria. (9384458)
1997
11
King George III and acute porphyria. (9024414)
1997
12
Markers for vulnerability in acute porphyria. A hypothesis paper. (7626691)
1995
13
Liver transplantation in a boy with acute porphyria due to aminolaevulinate dehydratase deficiency. (1493152)
1992
14
Acute porphyria in the emergency department. (2663971)
1989
15
Propofol in acute porphyria. (2787965)
1989
16
Meningism, pericarditis/myocarditis--unrecognized manifestations of acute porphyria. (3097350)
1986
17
Carbamazepine-induced acute porphyria syndrome. (6143958)
1984
18
Porphobilinogen-synthase (delta-aminolevulinic acid dehydratase) deficiency in bone marrow cells of two patients with porphobilinogen-synthase defect acute porphyria. (6887758)
1983
19
Alcohol in acute porphyria. (6123048)
1982
20
International review of drugs in acute porphyria--1980. (7004930)
1980
21
Porphyrin precursors in acute porphyria. (653477)
1978
22
Catecholamine uptake, accumulation, and release in acute porphyria. (908757)
1977
23
Pathogenesis of neural manifestations in acute porphyria. (870989)
1977
24
Hematin treatment of acute porphyria. Early remission of an almost fatal relapse. (946099)
1976
25
Intermittent acute porphyria: the enzymatic defect. (4280105)
1974
26
Simple and rapid screening for acute porphyria--'porphobilistix' and Hoesch test. (5150285)
1971
27
Abnormalities of the porphyrin metabolism in relatives of patients with acute porphyria. (5925932)
1966
28
Acute porphyria. (14012663)
1963
29
Peripheral neuropathy and the diagnosis of acute porphyria. (13982095)
1962
30
Glycine metabolism in acute porphyria. (13741260)
1961
31
Urinary excretion of porphobilinogen in acute porphyria. (13853339)
1960
32
An unusual case of acute porphyria with volvulus and gangrene of the cecum. (13424560)
1957
33
Acute porphyria. (13428299)
1957
34
Acute porphyria. (13318769)
1956
35
Studies on the incidence and heredity of acute porphyria in Sweden. (13354248)
1956
36
Acute porphyria with epileptiform convulsions. (13388999)
1956
37
Porphobilinogen and delta-amino levulinic acid in acute porphyria. (14357411)
1955
38
Pathology of acute porphyria; experimental porphyria in animals. (13159971)
1954
39
The prognosis of acute porphyria. (13042263)
1953
40
Acute porphyria; report of two cases of the idiopathic type. (13018360)
1952
41
Acute porphyria; a study of six cases. (13008905)
1952
42
Acute porphyria; case report with the use of urecholine in the management of obstipation. (14917188)
1952
43
A case of acute porphyria. (14890271)
1951
44
A note on the urinary uroporphyrin in acute porphyria. (16748651)
1950
45
Acute porphyria with spinal fluid changes. (14771747)
1950
46
The porphyrins of acute porphyria. The detection of hitherto unrecognized porphyrins. (16748650)
1950
47
Acute porphyria. (20344665)
1947
48
Acute porphyria. (20278706)
1947
49
Acute porphyria with changes in the coeliac ganglion and prominent abdominal symptoms. (21021816)
1945
50
Acute porphyria: Some properties of porphobilinogen. (16747936)
1945

Variations for Acute Porphyria

About this section

Expression for genes affiliated with Acute Porphyria

About this section
Search GEO for disease gene expression data for Acute Porphyria.

GO Terms for genes affiliated with Acute Porphyria

About this section

Cellular components related to Acute Porphyria according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial matrixGO:00057598.9ALAS1, ALAS2, FECH, PC
2mitochondrionGO:00057397.4ALAS1, ALAS2, CPOX, FECH, PC, PPOX

Biological processes related to Acute Porphyria according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1protoporphyrinogen IX metabolic processGO:004650110.5FECH, PPOX
2response to platinum ionGO:007054110.3ALAD, FECH
3response to vitaminGO:003327310.3ALAD, HMBS
4cellular response to amine stimulusGO:007141810.3HMBS, UROS
5porphyrin-containing compound biosynthetic processGO:000677910.2PPOX, UROS
6cellular response to dexamethasone stimulusGO:007154910.2FECH, HMBS
7response to insecticideGO:001708510.2CPOX, FECH
8response to zinc ionGO:001004310.1ALAD, HMBS
9response to cobalt ionGO:003202510.1ALAD, HMBS
10response to mercury ionGO:004668910.1ALAD, UROD
11response to metal ionGO:001003810.1ALAD, FECH
12response to inorganic substanceGO:001003510.0ALAD, CPOX
13cellular response to lead ionGO:007128410.0ALAD, HMBS
14response to amino acidGO:00432009.9ALAD, HMBS
15response to arsenic-containing substanceGO:00466859.6ALAD, CPOX, FECH
16cellular response to arsenic-containing substanceGO:00712439.6HMBS, UROD, UROS
17response to lead ionGO:00102889.6ALAD, CPOX, FECH
18cellular iron ion homeostasisGO:00068799.5ALAS2, HFE
19response to ethanolGO:00454719.2ALAD, FECH, UROD
20response to methylmercuryGO:00515978.9ALAD, CPOX, FECH, HMBS, UROD
21response to hypoxiaGO:00016668.7ALAD, ALAS2, HMBS
22response to drugGO:00424938.7ALAD, FECH, HMBS, PPOX
23response to iron ionGO:00100398.5ALAD, CPOX, HFE, UROD
24protoporphyrinogen IX biosynthetic processGO:00067827.2ALAD, ALAS1, ALAS2, CPOX, HMBS, PPOX
25heme biosynthetic processGO:00067837.0ALAD, ALAS1, ALAS2, CPOX, FECH, HMBS

Molecular functions related to Acute Porphyria according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1uroporphyrinogen-III synthase activityGO:00048529.9HMBS, UROS
25-aminolevulinate synthase activityGO:00038709.8ALAS1, ALAS2
3ferrous iron bindingGO:00081989.7FECH, UROD
4coenzyme bindingGO:00506629.6ALAS2, HMBS
5pyridoxal phosphate bindingGO:00301709.0ALAS1, ALAS2

Sources for Acute Porphyria

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet